SCHEMBL25926439

SCHEMBL25926439

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3c(-c5cccc6c5oc5ccc(-n7c8ccccc8c8ccccc87)cc56)cccc34)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.38
PRKDC P78527 4/20 0.38
PIK3CD O00329 1/20 0.34
PIK3CB P42338 1/20 0.34
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
PTGER4 P35408 1/20 0.33
PTPRF P10586 5/20 0.32
PTPN2 P17706 5/20 0.32
PTPN1 P18031 5/20 0.32
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GGPS1 O95749 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
MAPT P10636 1/20 0.31
PIM1 P11309 1/20 0.31
CSNK2A2 P19784 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25926443 0.97 ALOX5 (0.42) ALOX5PRKDCPIK3CDPIK3CBALDH1A1
SCHEMBL25926468 0.97 ALOX5 (0.42) ALOX5PRKDCPIK3CDPIK3CBALDH1A1
SCHEMBL25926586 0.96 ALOX5 (0.41) ALOX5PRKDCPIK3CDPIK3CBALDH1A1
SCHEMBL25926605 0.96 ALOX5 (0.41) ALOX5PRKDCPIK3CDPIK3CBALDH1A1
SCHEMBL25926505 0.96 ALOX5 (0.41) ALOX5PRKDCPIK3CDPIK3CBALDH1A1
SCHEMBL24215953 0.96 ALOX5 (0.39) ALOX5PRKDCPIK3CDPIK3CBALDH1A1
SCHEMBL25926331 0.96 ALOX5 (0.37) ALOX5PRKDCPIK3CDPIK3CBALDH1A1
SCHEMBL25926451 0.96 ALOX5 (0.41) ALOX5PRKDCPIK3CDPIK3CBALDH1A1
SCHEMBL21668798 0.96 ALOX5 (0.39) ALOX5PRKDCPIK3CDPIK3CBALDH1A1
SCHEMBL25926576 0.96 ALOX5 (0.38) ALOX5PRKDCPIK3CDPIK3CBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 ALOX5 959/4885PRKDC 3471/4885PIK3CD 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.